COMPANY OVERVIEW
Penzymes LLC is an early stage company developing Selective Intracrine Modulators (SIMs) to block the local formation of steroid hormones in hormone dependent maligancies of the prostate, breast and endometrium. Lead product s in development may benefit patients with castration resistant prostate cancer (CRPC), an area of huge unmet clinical need.
UNSOLVED CLINICAL NEED:
|